CONMED Corporation (CNMD) reported fourth-quarter 2025 results with revenue of $373.2 million, up 7.9% year over year but slightly below the consensus revenue estimate of $374.1 million. Diluted earnings per share were $0.54, down 50.0% year over year and well below the EPS estimate of $1.35.
Balance sheet and cash-flow highlights:
Market reaction: shares of CONMED (CNMD) were up about 2.6% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
CONMED Corporation Insider Trading Activity
CONMED Corporation insiders have traded $CNMD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CNMD stock by insiders over the last 6 months:
- TODD W GARNER (Executive Vice President & CFO) has made 0 purchases and 2 sales selling 4,098 shares for an estimated $181,865.
- CHARLES FARKAS has made 0 purchases and 2 sales selling 2,000 shares for an estimated $107,049.
- RICHARD GLAZE (Chief Information Officer) sold 257 shares for an estimated $10,590
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CONMED Corporation Hedge Fund Activity
We have seen 133 institutional investors add shares of CONMED Corporation stock to their portfolio, and 157 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 999,924 shares (+inf%) to their portfolio in Q3 2025, for an estimated $47,026,425
- MACQUARIE GROUP LTD removed 969,641 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $45,602,216
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 835,854 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $39,310,213
- CAPITAL RESEARCH GLOBAL INVESTORS removed 643,431 shares (-38.4%) from their portfolio in Q3 2025, for an estimated $30,260,559
- INVENOMIC CAPITAL MANAGEMENT LP added 420,003 shares (+inf%) to their portfolio in Q3 2025, for an estimated $19,752,741
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 221,799 shares (+26.0%) to their portfolio in Q3 2025, for an estimated $10,431,206
- DIMENSIONAL FUND ADVISORS LP added 214,126 shares (+19.8%) to their portfolio in Q3 2025, for an estimated $10,070,345
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CONMED Corporation Government Contracts
We have seen $214,105 of award payments to $CNMD over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CONMED AIRSEAL PREVENTATIVE MAINTENANCE: $59,340
- IMPLANT HARDWARE: $28,430
- SURGICAL DRILLS - HALL ORAL MAX ELITE HIGH-SPEED DRILL. CONMED CORP:1360303 [25-002465]: $26,629
- MAINTENANCE: $17,980
- IMPLANT HARDWARE: $12,390
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CONMED Corporation Price Targets
Multiple analysts have issued price targets for $CNMD recently. We have seen 4 analysts offer price targets for $CNMD in the last 6 months, with a median target of $52.0.
Here are some recent targets:
- Travis Steed from B of A Securities set a target price of $52.0 on 12/08/2025
- Matt O'Brien from Piper Sandler set a target price of $55.0 on 11/06/2025
- Vik Chopra from Wells Fargo set a target price of $47.0 on 11/06/2025
- Robbie Marcus from JP Morgan set a target price of $52.0 on 11/06/2025
